Biodesix Inc. (NYSE: BDSX) stock closed at 1.82 per share at the end of the most recent trading day (a 4% change compared to the prior day closing price) with a volume of 94.34K shares and market capitalization of 141.13M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 186 people. Biodesix Inc. CEO is Scott Hutton.

The one-year performance of Biodesix Inc. stock is -11.22%, while year-to-date (YTD) performance is -20.87%. BDSX stock has a five-year performance of %. Its 52-week range is between 0.955 and 3, which gives BDSX stock a 52-week price range ratio of 41.81%

Biodesix Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 5.64, a price-to-sale (PS) ratio of 6.34, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -76.23%, a ROC of -154.20% and a ROE of -889.43%. The company’s profit margin is -79.18%, its EBITDA margin is -129.30%, and its revenue ttm is $28.61 Million , which makes it $0.37 revenue per share.

Of the last four earnings reports from Biodesix Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.26 for the next earnings report. Biodesix Inc.’s next earnings report date is 10th May 2023.

The consensus rating of Wall Street analysts for Biodesix Inc. is Moderate Buy (1.67), with a target price of $7.33, which is +304.97% compared to the current price. The earnings rating for Biodesix Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biodesix Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biodesix Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.09, ATR14 : 0.21, CCI20 : -40.40, Chaikin Money Flow : -0.13, MACD : -0.08, Money Flow Index : 50.93, ROC : -9.00, RSI : 46.53, STOCH (14,3) : 53.65, STOCH RSI : 0.83, UO : 56.75, Williams %R : -46.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biodesix Inc. in the last 12-months were: Charles Watts (Buy at a value of $50 000), Gary Pestano (Option Excercise at a value of $0), Gary Pestano (Sold 4 596 shares of value $8 230 ), Hany Massarany (Buy at a value of $149 999), Jack W. Schuler (Buy at a value of $15 783 812), Jean M. Franchi (Option Excercise at a value of $0), John Patience (Buy at a value of $2 499 998), Jon Faiz Kayyem (Buy at a value of $200 000), Jon Faiz Kayyem (Option Excercise at a value of $0), Kieran O¿Kane (Option Excercise at a value of $0), Kieran O¿Kane (Sold 4 961 shares of value $8 885 ), Robert Georgantas (Option Excercise at a value of $0), Robert Georgantas (Sold 5 466 shares of value $9 761 ), Robin Harper Cowie (Option Excercise at a value of $0), Robin Harper Cowie (Sold 10 453 shares of value $18 734 ), Ryan H. Siurek (Option Excercise at a value of $0), Ryan H. Siurek (Sold 5 317 shares of value $9 500 ), Scott Hutton (Option Excercise at a value of $0), Scott Hutton (Sold 40 689 shares of value $72 973 )